IGF-1R/epithelial-to-mesenchymal transition (EMT) crosstalk suppresses the erlotinib-sensitizing effect of EGFR exon 19 deletion mutations
Alejandro Vázquez‐Martín(Catalan Institute for Water Research), Javier A. Menéndez(Catalan Institute for Water Research)
Cited by 94
Related Papers
The antidiabetic drug metformin suppresses HER2 (erbB-2) oncoprotein overexpression via inhibition of the mTOR effector p70S6K1 in human breast carcinoma cells
|Cell Cycle|2009|251
Autophagy Facilitates the Development of Breast Cancer Resistance to the Anti-HER2 Monoclonal Antibody Trastuzumab
|PLoS ONE|2009|245
Metformin Is a Direct SIRT1-Activating Compound: Computational Modeling and Experimental Validation
|Frontiers in Endocrinology|2018|122